Cytogenetic evolution of human ovarian cell lines associated with chemoresistance and loss of tumorigenicity

Anal Cell Pathol. 2003;25(3):115-22. doi: 10.1155/2003/151042.

Abstract

In order to identify genomic changes associated with a resistant phenotype acquisition, we used comparative genomic hybridization (CGH) to compare a human ovarian cell line, Igrov1, and four derived subcell lines, resistant to vincristine and presenting a reversion of malignant properties. Multicolor FISH (Multiplex-FISH and Spectral Karyotype) and conventional FISH are also used to elucidate the karyotype of parental cell line. The drug-resistant subcell lines displayed many chromosomal abnormalities suggesting the implication of different pathways leading to a multidrug resistance phenotype. However, these cell lines shared two common rearrangements: an unbalanced translocation der(8)t(8;13)(p22;q?) and a deletion of the 11p. These chromosomal imbalances could reflected the acquisition of the chemoresistance (der(8)) or the loss of tumorigenicity properties (del(11p)).

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Cell Line, Tumor
  • Chromosome Aberrations
  • Cytogenetics
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / pathology
  • Phenotype
  • Polyploidy
  • Vincristine / pharmacology

Substances

  • Antineoplastic Agents, Phytogenic
  • Vincristine